Taro Pharmaceutical Industries Ltd. Provides Results For December 31, 2015
HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the three and nine months ended December 31, 2015.
Quarter ended December 31, 2015 Highlights - compared to December 31, 2014
• Net sales of $258.3 million, increased $20.6 million, or 8.7%, on marginally increased volumes
Quarter ended December 31, 2015 Highlights - compared to December 31, 2014
• Net sales of $258.3 million, increased $20.6 million, or 8.7%, on marginally increased volumes